A new study reveals that scratching is not just an annoying reflex — it plays a dual role in immune activation and pathogen ...
Odell Beckham Jr. revealed he was diagnosed with a chronic skin condition known as seborrheic dermatitis that causes itching.
The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for bullous pemphigoid by June 20, 2025.
Is chronic overwhelm disrupting your work, wellbeing and relationships? Here's how to bring some calm and balance into your ...
An AI-enabled wearable sensor with vibratory feedback significantly reduces nocturnal scratching in atopic dermatitis, ...
The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid (BP).
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...
If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025Priority ...
Treating eczema starts with a solid skincare routine, but you may need more than just moisturizer to get you through a flare-up.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback